Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03288207 · ClinicalTrials.gov registry record · NA

Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

A NA study of Obesity, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Recruiting
Registry status
NA
Development phase
325
Enrollment target
1
Study location

NCT03288207 is a NA study of Obesity that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 325 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03288207, a NA study of Obesity, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

RECRUITING
Registry status
NA
Development phase
325 participants
Enrollment target
1
Study location

Study Summary

Background: Heart disease is a leading cause of death. People can reduce their heart disease risk by exercising more. Mobile health technology may make people more successful at increasing their exercise. This includes things like physical activity monitors and smartphone apps. Objective: To find out if mobile health technology can increase physical activity. Eligibility: African American women ages 21-75 who: * Are overweight or obese * Live in certain areas near Washington, DC * Have a smartphone that can use the study app Design: At visit 1, participants will * Answer survey questions. These may be about medical history, physical activity, and weight. They may also cover body image, health perception, and spirituality. * Have body size measured and get blood tests * Get a device to wear on the wrist. It will record physical activity and hours of sleep. * Learn how to download and use the study mobile app For 2 weeks, researchers will collect data about participants physical activity. Then participants will have a study visit with additional blood tests. All participants will get messages from the app that encourage exercise. Some participants will get data from the app about exercise near their home or work. Some participants may get face-to-face coaching. Participants may get wireless devices. These measure body weight, blood pressure, and blood glucose. Participants can measure these at home and upload the data to the app for the study. Participants will have visits after 3 and 6 months. They will repeat the visit 1 tests. ...

Conditions Studied

Interventions

  • DEVICE Step it Up mobile app
  • DEVICE Global Positioning System (GPS) Device
  • DEVICE Bluetooth-enabled scale
  • DEVICE Bluetooth-enabled glucometer
  • DEVICE MRI: Image Reconstruction and Analysis Software (Device Manufacturer: NIH)

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 325 participants
Start Date 2018-06-21
Est. Completion 2026-08-04
Phase NA

What the Registry Record Tells You About NCT03288207

The ClinicalTrials.gov registry entry for NCT03288207 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (60% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Step it Up mobile app is the first listed.

NCT03288207 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03288207 about?

NCT03288207 is a clinical study titled "Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments". Background: Heart disease is a leading cause of death. People can reduce their heart disease risk by exercising more. Mobile health technology may make people more successful at increasing their exercise. This includes things like physical activity monitors and smartphone apps. Objective: To find...

What is the current status of trial NCT03288207?

This trial is currently recruiting. It is a NA study. The enrollment target is 325 participants. The study started on 2018-06-21. Estimated completion is 2026-08-04.

What conditions does trial NCT03288207 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03288207?

The interventions under investigation include: Step it Up mobile app (DEVICE), Global Positioning System (GPS) Device (DEVICE), Bluetooth-enabled scale (DEVICE), Bluetooth-enabled glucometer (DEVICE), MRI: Image Reconstruction and Analysis Software (Device Manufacturer: NIH) (DEVICE).

Who is sponsoring clinical trial NCT03288207?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03288207 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.